Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 EUR | -1.84% | -13.28% | +43.37% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Sales 2024 * | 4.7M 5.09M | Sales 2025 * | 8.7M 9.42M | Capitalization | 98.36M 107M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.33M | Net income 2025 * | -16M -17.33M | EV / Sales 2024 * | 6.91 x |
Net cash position 2024 * | 65.9M 71.37M | Net cash position 2025 * | 52.2M 56.53M | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
-6.04
x | P/E ratio 2025 * |
-6.04
x | Employees | 81 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.93% |
Latest transcript on Nightingale Health Oyj
1 day | +1.23% | ||
1 week | -10.57% | ||
Current month | -7.82% | ||
1 month | +28.91% | ||
3 months | +48.92% | ||
6 months | +40.31% | ||
Current year | +47.85% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 1.6 | -1.84% | 47 006 |
24-05-14 | 1.63 | -1.21% | 77,753 |
24-05-13 | 1.65 | -7.82% | 114,644 |
24-05-10 | 1.79 | -2.98% | 68,806 |
24-05-08 | 1.845 | -2.89% | 61,567 |
Delayed Quote Nasdaq Helsinki, May 15, 2024 at 04:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.85% | 106M | |
+5.87% | 32.94B | |
+21.53% | 7.83B | |
+34.69% | 4.26B | |
-27.79% | 2.74B | |
-19.53% | 1.39B | |
-28.50% | 1.27B | |
-32.48% | 1.17B | |
+10.53% | 988M | |
-36.79% | 884M |
- Stock Market
- Equities
- HEALTH Stock